Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 658.62M P/E - EPS this Y 1.40% Ern Qtrly Grth -
Income -252.45M Forward P/E -2.74 EPS next Y -8.40% 50D Avg Chg -15.00%
Sales 10.6M PEG - EPS past 5Y - 200D Avg Chg -41.00%
Dividend N/A Price/Book 1.18 EPS next 5Y - 52W High Chg -64.00%
Recommedations 1.70 Quick Ratio 15.61 Shares Outstanding 118.22M 52W Low Chg 5.00%
Insider Own 4.88% ROA -18.20% Shares Float 90.74M Beta 0.89
Inst Own 97.18% ROE -28.36% Shares Shorted/Prior 11.98M/12.92M Price 9.30
Gross Margin - Profit Margin - Avg. Volume 1,032,227 Target Price 66.09
Oper. Margin -4,040.39% Earnings Date Nov 6 Volume 592,968 Change -2.31%
About Avidity Biosciences, Inc.

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

Avidity Biosciences, Inc. News
10/04/24 Why Avidity Biosciences Zoomed to a 12% Gain This Week
10/04/24 FDA lifts clinical hold on Avidityโ€™s lead antibody conjugate therapy trial
10/03/24 Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
09/29/24 Is Avidity Biosciences, Inc. (RNA) the Best Performing Long Term Stock in 2024?
09/26/24 Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?
09/25/24 Avidity Biosciences to Participate in Upcoming Investor Conference
09/23/24 Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/05/24 Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month
08/28/24 Avidity Biosciences to Participate in Upcoming Investor Conferences
08/20/24 Avidity, Kymera raise fresh funds; Walgreens partners with BARDA
08/19/24 Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
07:29 PM Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
08/13/24 Avidity Biosciences Announces Proposed Public Offering of Common Stock
08/13/24 Company News for Aug 13, 2024
08/09/24 Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Misses Revenue Estimates
08/09/24 How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics
08/09/24 Avidity Biosciences Reports Second Quarter 2024 Financial Results and Recent Highlights
08/09/24 Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping in the Phase 1/2 EXPLORE44โ„ข Trial
08/05/24 Avidity Biosciences Announces Appointment of John B. Moriarty, Jr. as Chief Legal Officer
07/24/24 3 Stocks Doing Even Better Than Superstar Super Micro (SMCI)
RNA Chatroom

User Image Swing_Trader_No_1 Posted - 3 hours ago

$RNA Quite board! What is the next bit of news to move this? BO? Phase 1/2 results?

User Image Bugseason Posted - 1 day ago

@McGrumpstine i have a whole different line up with 100% pop $RNA $AUTL $SGMO $ALT but I am looking at atara closely.

User Image Bromberger Posted - 4 days ago

$RNA It was a hard day for all markets. But tomorrow we should be back in the right direction ๐Ÿš€

User Image enz12 Posted - 4 days ago

$RNA crooks want Your shares. Hold to 80 minimum

User Image insiderbuyingselling Posted - 4 days ago

$RNA new insider selling: 30000 shares. http://insiderbuyingselling.com/?t=RNA

User Image enz12 Posted - 1 week ago

$RNA pt80 eoy

User Image Stockswingalert Posted - 1 week ago

$RNAC $WVE more after hours lezzz go $PRQR $RNA Proving myself after many years of bio bags ๐Ÿ˜‚๐Ÿ˜‚๐Ÿ˜‚

User Image ashu3889 Posted - 1 week ago

$RNA https://www.tickerscanner.com/chart/?exchange=NASDAQ&symbol=RNA Note: Not a financial advise, please consult your financial advisor before making any investment decisions.

User Image uberkauft Posted - 1 week ago

$RNA Avidity Biosciences, Inc. 14-Day RSI: 60.0 % from 52-Week Low: +875.1% % from 52-Week High: -4.8% Open Interest: 5,922 % Change: +9% Put/Call Ratio: 0.96 % Change: +13.0%

User Image yloo Posted - 1 week ago

$CPHI to $.33-$.38 WL next week $BILI $TSLA $GEHC $RNA

User Image AdiDasRom Posted - 1 week ago

$RNA Good News "FDA Lifts Clinical Review of Avidity's Lead Antibody Conjugate Therapy Study" yahoo.finance

User Image Bromberger Posted - 1 week ago

$RNA

User Image AdiDasRom Posted - 1 week ago

$RNA bullish

User Image OpenOutcrier Posted - 1 week ago

$RNA (+3.1% pre) Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001) - Stock Titan https://ooc.bz/l/43866

User Image DonCorleone77 Posted - 1 week ago

$RNA Avidity announces FDA removed partial clinical hold on Delpacibart Etedesiran Avidity Biosciences announced that the U.S. Food and Drug Administration, FDA, has removed the partial clinical hold on delpacibart etedesiran, an investigational treatment designed to address the root cause of myotonic dystrophy type 1.

User Image enz12 Posted - 1 week ago

$RNA BMY will buy this 80 +++

User Image skiparock Posted - 1 week ago

$RNA they must have said something right in the conference this morning

User Image bigkahunatrader Posted - 09/30/24

$RNA Avidity Biosciences, Inc. in PBC Zone..high scoring setup https://youtube.com/shorts/OoKcurbvyt0?feature=share

User Image Avocado_smash Posted - 09/30/24

$RNA

User Image yloo Posted - 09/30/24

$CBAT wL this week $DJT $DADA $SMMT $RNA

User Image peabody86 Posted - 09/26/24

$RNA Added 1k @42ish ...guess we will find out if that was a smart move or not....

User Image CDCcsd Posted - 09/26/24

$RNA Just noticed that Goldman Sachs just picked up coverage of RNA, never a good sign. My experience is that when GS gets involved in your stock it's best to sell.

User Image Himel92 Posted - 09/26/24

The Last month Performance for $RNA Opening Price: $43.76 Closing Price: $45.95 Highest Price: $46.54 Lowest Price: $39.35 Percentage Change: 5.00% Data analyst: AITX

User Image CDCcsd Posted - 09/26/24

$RNA Secondary coming ?

User Image Avocado_smash Posted - 09/26/24

$HKD $WULF $LX $LEVI $RNA BB EXPANDING

User Image Avocado_smash Posted - 09/25/24

$RNA BB EXPANDING.

User Image insiderbuyingselling Posted - 09/23/24

$RNA new insider selling: 32880 shares. http://insiderbuyingselling.com/?t=RNA

User Image insiderbuyingselling Posted - 09/20/24

$RNA new insider selling: 5000 shares. http://insiderbuyingselling.com/?t=RNA

User Image AdiDasRom Posted - 09/20/24

$RNA

User Image peabody86 Posted - 09/19/24

$RNA almost 1.6m in T-trades AH...it means something,but what? Big news? Someone should buy them out right now...

Analyst Ratings
Goldman Sachs Buy Sep 24, 24
Cantor Fitzgerald Overweight Sep 18, 24
Cantor Fitzgerald Overweight Sep 16, 24
Cantor Fitzgerald Overweight Sep 9, 24
Barclays Overweight Aug 28, 24
Evercore ISI Group Outperform Aug 26, 24
Needham Buy Aug 13, 24
Evercore ISI Group Outperform Aug 12, 24
Chardan Capital Buy Aug 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LEVIN ARTHUR A Director Director Jan 22 Sell 10.13 1,859 18,832 17,471 01/23/24
Boyce Sarah President and CEO President and CEO Jan 20 Sell 10.13 5,092 51,582 44,008 01/23/24
Flanagan W. Michael CSTO CSTO Jan 20 Sell 10.13 4,129 41,827 35,871 01/23/24
McCarthy Teresa Chief Human Resource.. Chief Human Resources Officer Jan 20 Sell 10.13 2,065 20,918 17,035 01/23/24
MacLean Michael F Chief Financial Offi.. Chief Financial Officer Jan 20 Sell 10.13 1,616 16,370 16,884 01/23/24
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Feb 14 Sell 23.93 10,000 239,300 19,330 02/15/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Feb 14 Option 1.24 10,000 12,400 29,330 02/15/23
Boyce Sarah President and CEO President and CEO Feb 01 Sell 24.3 50,000 1,215,000 53,352 02/03/23
Boyce Sarah President and CEO President and CEO Feb 01 Option 1.24 50,000 62,000 56,573 02/03/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jan 12 Sell 22 10,000 220,000 1,330 01/17/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jan 12 Option 1.24 10,000 12,400 11,330 01/17/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Dec 29 Sell 22.01 40,000 880,400 1,330 01/03/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Dec 29 Option 1.24 40,000 49,600 41,330 01/03/23
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Aug 12 Option 0.89 80,000 71,200 4,829 08/31/22
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Aug 12 Sell 22.07 80,000 1,765,600 1,330 08/31/22
Boyce Sarah President and CEO President and CEO Aug 24 Option 1.24 49,900 61,876 14,855 08/26/22
Boyce Sarah President and CEO President and CEO Aug 24 Sell 22.93 49,900 1,144,207 08/26/22
Boyce Sarah President and CEO President and CEO Aug 15 Option 1.24 100 124 100 08/17/22
Boyce Sarah President and CEO President and CEO Aug 15 Sell 22.47 100 2,247 08/17/22
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 28 Option 1 20,200 20,200 21,430 06/28/21
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 22 Option 1.24 200 248 1,530 06/22/21
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 22 Sell 27.75 200 5,550 1,330 06/22/21
LEVIN ARTHUR A Chief Scientific Off.. Chief Scientific Officer Jun 16 Sell 25.97 37,022 961,461 06/16/21